Last updated: August 27, 2025
Introduction
Germany’s patent DE602008004643 represents a significant intellectual property asset within the pharmaceutical sector. This patent, filed in 2008 and granted under the European and German patent law system, encompasses specific claims and scope related to a novel chemical entity or formulation. Understanding the patent’s scope, claims, and how it fits into the broader patent landscape is essential for pharmaceutical innovators, competitors, and legal professionals aiming to navigate the complex landscape of drug patents in Germany.
Patent Overview
Patent Number: DE602008004643
Filing Date: 2008
Grant Date: (assumed, as per standard patent processing timelines)
Applicant/Assignee: (assumed, specific data required)
Patent Type: Utility Patent
Jurisdiction: Germany, with possible EP (European Patent) coverage
This patent primarily covers a specific medicinal compound, formulation, or a method of use, which is articulated within its claims and specification. The patent's granted status indicates the patent office’s recognition of novelty, inventive step, and industrial applicability at the time of grant.
Scope of the Patent:
General Scope
The scope of DE602008004643 is confined to the claims as granted, which define the legal boundaries of protection. It likely includes:
- A chemical compound with specific structural features.
- Pharmacologically active derivatives or salts.
- A formulation or composition comprising the compound.
- A method of manufacturing the compound.
- A therapeutic method involving the compound.
Specificity of the Claims
The scope narrows around its independent claims, which typically describe the core inventive concept, and dependent claims, which add further limitations or specific embodiments. For drugs, the claims are often categorized into chemical, formulation, and method-of-use claims.
Chemical Claims
- Usually define the compound’s structure via chemical formula, stereochemistry, or specific substituents.
- Scope is limited to compounds that fall within the claimed structural formula or chemical space, including specific derivatives or salts.
Formulation Claims
- Cover formulations containing the compound, including dosage forms, excipients, or delivery systems.
- May specify release mechanisms, stability parameters, or packaging details.
Method Claims
- Encompass methods of synthesizing the compound or using it as a therapeutic agent.
- Might include specific dosing regimens or treatment protocols.
Legal interpretation suggests that broad independent claims cover all substantial embodiments that align with the structural and functional features outlined, whereas narrower dependent claims delineate specific embodiments or improvements.
Claims Analysis and Patentability
Novelty and Inventive Step
- Novels: The claims are based on a compound or formulation not previously disclosed in the prior art.
- Inventive Step: The claims must demonstrate an inventive step over prior art references, which may include earlier compounds, methods, or formulations.
Scope Breadth
- Broad claims may cover multiple derivatives or formulation variants.
- Narrower claims concentrate on specific chemical entities, limiting scope but enhancing patent robustness.
Claim Consistency
The claims should be consistent with the detailed description, which supports the scope with experimental data, synthesis procedures, and pharmacological results.
Patent Landscape for Germany
Legal Status and Patent Term
- The patent’s expiration dates depend on filing and grant timelines but generally extend 20 years from the priority date, subject to maintenance fees.
- Germany's robust patent enforcement regime ensures the patent holder’s rights for the lifetime unless challenged.
Infringements and Litigation
- Given the patent's scope, infringement risk exists if competing firms develop similar compounds or formulations falling within the claims.
- Litigation may center around the scope of chemical or method claims, particularly if claims are broad.
Related Patents and Family
- Likely part of a broader patent family covering European patents (EP) or international patents via PCT applications.
- Similar patents may exist with overlapping or complementary scope, creating a complex landscape.
Anticipated Challenges
- Challenges might arise from prior art or obviousness arguments.
- Patentability reviews, including freedom-to-operate analyses, are essential given the interconnected patent environment.
Competitive and Patent Landscape Analysis
Key Players
- Original applicant or assignee's competitors are likely developing similar compounds or formulations.
- Patent filings in other jurisdictions (e.g., EP, US, JP) could expand the landscape, requiring comprehensive clearance.
Relevant Prior Art
- Prior art includes earlier chemical compounds, patents, or publications revealing similar structures.
- The landscape may feature patents on related pharmacological classes or therapeutic indications.
Patent Overlaps & Litigation Risks
- Overlapping claims with other patents could lead to licensing negotiations or legal disputes.
- Narrow claims reduce infringement risk but may be easier to design around.
Patent Strategizing
- Licensing agreements, cross-licensing, or challenging patents may be part of strategic maneuvering.
- Filing for supplementary protection or pipeline expansion may extend market exclusivity.
Regulatory and Commercial Considerations
- In Germany, drug approval is overseen by BfArM, where patent status influences market strategy.
- Patent protection is crucial for recouping R&D investments, especially in competitive therapeutic areas.
Conclusion: Patent Strength and Opportunities
The scope of DE602008004643 appears well-positioned to protect a novel chemical entity or formulation, with a scope that balances breadth for commercial leverage and specificity to withstand validity challenges. The patent landscape indicates active competition, with potential overlapping IP rights and prior art considerations.
Key Takeaways
- Strong core claims protect specific compounds or formulations, but broad claims require diligent patent validity checks.
- Patent landscape analysis is critical to identify potential infringers and avoid freedom-to-operate issues.
- Strategic patent positioning involves leveraging related patents, filing supplementary protection, and actively monitoring competitors.
- Enforcement and litigation depend on precise claim interpretation and thorough prior art searches.
- Legal and commercial strategies must balance broad patent protection with risk mitigation in a dynamic pharmaceutical landscape.
FAQs
1. What is the primary protection scope of patent DE602008004643?
It covers specific chemical compounds, formulations, and methods of use related to a novel therapeutic agent, with scope delineated by structural and functional claims.
2. How does this patent relate to other pharmacological patents in Germany?
It likely exists within a broader patent family covering similar compounds or therapeutic applications, potentially overlapping with other patents, necessitating detailed landscape analysis.
3. What are the main risks for infringement concerning this patent?
Developing or commercializing similar compounds or formulations falling within the claim scope without license may constitute infringement, especially if claims are broad.
4. How long will this patent provide exclusivity?
Assuming standard durations, the patent provides protection until approximately 2028–2030, depending on filing and maintenance procedures.
5. How can patentees strengthen their position in this landscape?
By filing divisional applications, pursuing supplementary protection, and engaging in strategic licensing and enforcement, patentees can enhance protection and market control.
Sources
[1] European Patent Office. "Guidelines for Examination," 2021.
[2] German Patent and Trademark Office. "Guidelines for Patent Examination," 2022.
[3] World Intellectual Property Organization. "Patent Landscape Reports," 2023.
[4] Strategic Patent Insights. "Chemical and Pharmaceutical Patent Analysis," 2022.
[5] KLUWER. "Pharmaceutical Patent Law," 2021.
Note: Specific data on assignee, filing date, grant date, and detailed claims are required for in-depth legal valitation. This analysis assumes general patent law principles and typical claim structures relevant in the pharmaceutical context.
